Old wine into new bottles. A critical evaluation of transdermal clonidine in the treatment of hypertension Christopher J. Mathias Editorial Pages: 355 - 355
Transdermal treatment with clonidine—a new approach in the management of hypertension G. Mancia Introduction Pages: 356 - 356
Hypertension and coronary heart disease risk factor management M. C. Houston Research Paper Pages: 357 - 361
Effect of antihypertensive formulation on health service expenditures D. A. SclarT. L. SkaerM. A. Gill Research Paper Pages: 363 - 368
Dose linearity of clonidine after transdermal application G. WallensteinV. Gladigau Research Paper Pages: 369 - 372
Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension R. E. KollochL. MehlburgerB. O. Göbel Research Paper Pages: 373 - 378
One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension — a multicentre open label study The Antihypertensive Patch Italian Study (APIS) Investigators Research Paper Pages: 379 - 383
Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension J. BreidthardtH. SchumacherL. Mehlburger Research Paper Pages: 385 - 390
The USA experience with the clonidine transdermal therapeutic system J. F. Burris Research Paper Pages: 391 - 396
The sympathetic nervous system and hypertension: Mechanisms and treatment M. A. Weber Conclusion Pages: 397 - 398